Omada Health (NASDAQ:OMDA) Price Target Lowered to $17.00 at Barclays

Omada Health (NASDAQ:OMDA) had its price objective reduced by Barclays from $22.00 to $17.00 in a research note published on Tuesday,Benzinga reports. They currently have an overweight rating on the stock.

A number of other brokerages have also recently issued reports on OMDA. Needham & Company LLC reissued a “buy” rating and set a $28.00 price objective on shares of Omada Health in a report on Thursday, January 22nd. BMO Capital Markets assumed coverage on shares of Omada Health in a report on Thursday, November 13th. They issued an “outperform” rating and a $27.00 price target on the stock. Wells Fargo & Company assumed coverage on shares of Omada Health in a research report on Thursday, January 8th. They issued an “equal weight” rating and a $17.00 price objective for the company. The Goldman Sachs Group reiterated a “buy” rating and issued a $26.00 target price on shares of Omada Health in a research note on Friday, January 16th. Finally, Evercore raised their price target on shares of Omada Health from $27.00 to $28.00 and gave the company an “outperform” rating in a report on Friday, November 7th. Eight investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $24.60.

Omada Health Price Performance

NASDAQ:OMDA opened at $13.00 on Tuesday. Omada Health has a 1 year low of $10.28 and a 1 year high of $28.40. The stock’s fifty day moving average price is $14.16 and its two-hundred day moving average price is $18.80. The company has a market cap of $752.83 million and a P/E ratio of -52.00.

Insider Activity

In related news, President Wei-Li Shao sold 5,618 shares of the firm’s stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $16.13, for a total transaction of $90,618.34. Following the transaction, the president directly owned 69,079 shares of the company’s stock, valued at approximately $1,114,244.27. This trade represents a 7.52% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Sean P. Duffy sold 230,479 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $15.60, for a total value of $3,595,472.40. Following the completion of the sale, the chief executive officer owned 126,644 shares of the company’s stock, valued at $1,975,646.40. The trade was a 64.54% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 276,893 shares of company stock worth $4,336,787 over the last quarter.

Institutional Investors Weigh In On Omada Health

A number of hedge funds have recently made changes to their positions in the business. XTX Topco Ltd bought a new position in shares of Omada Health during the 4th quarter valued at $297,000. Utah Retirement Systems purchased a new stake in Omada Health during the fourth quarter valued at about $1,237,000. VARCOV Co. bought a new position in shares of Omada Health during the fourth quarter valued at about $504,000. Voloridge Investment Management LLC purchased a new position in shares of Omada Health in the fourth quarter worth about $2,590,000. Finally, Tudor Investment Corp ET AL increased its holdings in shares of Omada Health by 373.7% in the fourth quarter. Tudor Investment Corp ET AL now owns 211,416 shares of the company’s stock worth $3,336,000 after buying an additional 166,783 shares during the period.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.